161 Recruiting Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Lymphoma Studies
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
📍 University Of Colorado — Aurora, Colorado
View Study & Checklist ➔Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy
📍 Huntsman Cancer Institute at University of Utah — Salt Lake City, Utah
View Study & Checklist ➔TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
📍 Stanford Medicine Cancer Center — Palo Alto, California
View Study & Checklist ➔A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
View Study & Checklist ➔Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
📍 Mass General Brigham — Boston, Massachusetts
View Study & Checklist ➔Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
View Study & Checklist ➔ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
📍 Columbia University — New York, New York
View Study & Checklist ➔AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
📍 Research Site — Duarte, California
View Study & Checklist ➔Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
View Study & Checklist ➔A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
📍 Alta Bates Summit Medical Center — Berkeley, California
View Study & Checklist ➔Combination Chemotherapy With or Without Autologous Stem Cell Transplant in Treating Patients With Central Nervous System B-Cell Lymphoma
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
📍 Stanford — Stanford, California
View Study & Checklist ➔Vaccine Responses in Patients With B Cell Malignancies
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
📍 Northwestern University (Data Collection Only) — Evanston, Illinois
View Study & Checklist ➔Living Well With Lymphoma
📍 University of Michigan — Ann Arbor, Michigan
View Study & Checklist ➔A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
📍 City of Hope Phoenix — Goodyear, Arizona
View Study & Checklist ➔An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
📍 Stanford Cancer Institute — Stanford, California
View Study & Checklist ➔Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Study of CAR-T Therapy in Older Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Axi-cel in CNS Lymphoma
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
📍 National Cancer Institute Developmental Therapeutics Clinic — Bethesda, Maryland
View Study & Checklist ➔Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Digital Peer Navigation for Adolescents and Young Adults With Cancer
📍 University Health Network — Toronto, Ontario
View Study & Checklist ➔Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
📍 Houston Methodist Hospital — Houston, Texas
View Study & Checklist ➔Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Navigating the Clinical Research Process for Lymphoma
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Nasal NK Cell Lymphoma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
📍 Mass General Hospital — Boston, Massachusetts
View Study & Checklist ➔